Literature DB >> 19833454

[Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: a randomized controlled trial].

M Fekih1, A Jnifene, K Fathallah, L Ben Regaya, A Memmi, S Bouguizene, A Chaieb, M Bibi, H Khairi.   

Abstract

OBJECTIVES: To assess the benefit of sublingual misoprostol in addition to standard oxytocin in the prevention of post-partum hemorrhage at caesarean section. PATIENTS AND METHODS: This was a prospective randomized controlled clinical trial conducted from March to June 2007 at our department of obstetrics-Sousse-Tunisia, including 250 single low risk pregnant women undergoing caesarean section at gestational age>32 weeks gestation. Patients were randomly assigned to receive at cord clamping either sublingual 200microg misoprostol (Cytotec) with 20UI intravenous oxytocin (Oxytocin): bolus 10UI and infusion 10UI in 500ml Ringer Lactate): Group I, or only oxytocin at the same dose: Group II. The main outcome was total blood loss assessed by decrease in perioperative hematocrit. Secondary outcomes included measured collected blood loss, drop in hemoglobin level, additional oxytocin, side-effects and postoperative complications.
RESULTS: The two groups were similar in demographic and obstetrical patient characteristics. Drop in hematocrit was more important in group II than in group I: 4.30%+/-3.14 versus. 1.10%+/-3.25; P=0.013. Drop in hemoglobin level was also more important in group II than in group I: 1.03g/dl+/-1.19 versus 0.54g/dl+/-1.17; P<0.01. Collected blood loss was less important in group I than in group II: 669.68cc+/-333.01 versus 852.52cc+/-295.08 ; P<0.01. Need for additional oxytocin and postoperative complications rate were more frequent in group II than in group I but the differences weren't significant. The rate of transient shivering, nausea and fever was significantly higher among women receiving misoprostol.
CONCLUSIONS: Sublingual misoprostol (in addition to oxytocin) is effective in prevention of post-partum hemorrhage at caesarean sections when compared to oxytocin alone, without major side-effects. Larger studies are needed to confirm our results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833454     DOI: 10.1016/j.jgyn.2009.09.006

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  5 in total

1.  Sublingual misoprostol to reduce blood loss at cesarean delivery.

Authors:  Atul Kumar Sood; Sanjay Singh
Journal:  J Obstet Gynaecol India       Date:  2012-06-01

Review 2.  Prostaglandins for preventing postpartum haemorrhage.

Authors:  Özge Tunçalp; G Justus Hofmeyr; A Metin Gülmezoglu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 3.  Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: a systematic review and metaanalysis.

Authors:  Agustín Conde-Agudelo; Aníbal Nieto; Anyeli Rosas-Bermudez; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2013-03-15       Impact factor: 8.661

4.  Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Authors:  Ioannis D Gallos; Argyro Papadopoulou; Rebecca Man; Nikolaos Athanasopoulos; Aurelio Tobias; Malcolm J Price; Myfanwy J Williams; Virginia Diaz; Julia Pasquale; Monica Chamillard; Mariana Widmer; Özge Tunçalp; G Justus Hofmeyr; Fernando Althabe; Ahmet Metin Gülmezoglu; Joshua P Vogel; Olufemi T Oladapo; Arri Coomarasamy
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19

Review 5.  Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Authors:  Ioannis D Gallos; Helen M Williams; Malcolm J Price; Abi Merriel; Harold Gee; David Lissauer; Vidhya Moorthy; Aurelio Tobias; Jonathan J Deeks; Mariana Widmer; Özge Tunçalp; Ahmet Metin Gülmezoglu; G Justus Hofmeyr; Arri Coomarasamy
Journal:  Cochrane Database Syst Rev       Date:  2018-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.